To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Star Trek Tricorder revisited: Toward a genre of medical scanners
06-01-2012: A hand-held scanner, reminiscent of the fictional Star Trek medical Tricorder, images blood vessels through the skin and projects a map onto the skin showing nurses exactly where to insert a needle. A pocket-sized device checks blood sugar levels through the skin of people with diabetes — no pinprick or blood sample needed. Those innovations are among a new genre of medical imaging technology that's giving doctors and scientists noninvasive views into the body to diagnose and study diseases. A report on the topic appears in Chemical & Engineering News.
In the article, Aaron Alexander Rowe focuses on new optical techniques that use laser beams or so-called near-infrared light to peer painlessly below the skin and through muscle and bone to see body structures. Near-infrared light, just beyond the range visible to the human eye, penetrates several inches into the human body. Two devices described in the article project a near-infrared beam into the skull. The light passes through brain tissue and blood vessels, and then scatters back out, where detectors analyze it in ways that promise to reveal whether patients are bleeding from a stroke or have other disorders.
The article explains that some of the new light-based medical diagnostic tools — the blood vessel mapper, for instance — already are in use in hospitals and clinics. Others are in various stages of pre-clinical development, including devices intended to spot skin cancer, monitor how breast cancer is responding to treatments and produce 3-D images of blockages in blood vessels.
- 1Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 2Panspecific antibodies: Novimmune successful in multiple specificities
- 3Takara Bio to Acquire Clontech Unit of BD Biosciences
- 4Michael Schlenk New Chief Executive Officer of Centogene Holding AG
- 5Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 6Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- 7Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 8Fresenius to acquire US drug-maker APP Pharmaceuticals in US$3.7 billion deal
- 9DSM Sinochem Pharmaceuticals opens new 6-APA intermediate plant in China
- 10Novirio Pharmaceuticals Limited Becomes Idenix Pharmaceuticals , Inc.
- Aethlon MedicalDiscloses Ebola Treatment Pathways in the United States
- Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents
- Figuring out how we get the nitrogen we need
- UF researchers discover leukemia’s hiding places
- Nabsys Appoints Anthony Shuber as Chief Scientific Officer